The information on this site is intended for Healthcare Professionals only
If you are a Healthcare Professional based in the UK or Ireland please choose from one of the following options to visit the relevant website:
*This promotional site is only intended for healthcare professionals seeking information on ZEPOSIA®▼ (ozanimod) in the UK or Ireland
If you are a patient or member of the general public based in the UK or Ireland, please click the option below.
Report adverse events (healthcare professionals in the UK or Ireland)
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Adverse events should be reported. Reporting forms and information can be found at:
UK - www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store.
Ireland - via HPRA Pharmacovigilance at www.hpra.ie
Adverse events should also be reported to Bristol-Myers Squibb via
medical.information@bms.com or 0800 731 1736 (UK); 1 800 749 749 (Ireland)
© 2022 Bristol-Myers Squibb Company. All rights reserved.
Job: 2084-GB-2300311 Date of Preparation: June 2023
Report possible side effects (patients and members of the public in the UK or Ireland)
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly.
UK - see www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store for how to report side effects.
Ireland - via HPRA Pharmacovigilance at www.hpra.ie
Side effects should also be reported to Bristol-Myers Squibb via
medical.information@bms.com or 0800 731 1736 (UK); 1 800 749 749 (Ireland)
© 2022 Bristol-Myers Squibb Company. All rights reserved.
Job: 2084-GB-2300311 Date of Preparation: June 2023